Abstract Background Carbapenem resistance among Acinetobacter species has become a
life-threatening problem. As a last resort in the treatment of gram-negative bacteria infection …

Carbapenem‐resistant Acinetobacter baumannii has been known as an opportunistic
pathogen that causes a variety of illness worldwide. In this study, we characterize the …

This study investigated the molecular epidemiology of carbapenem-resistant Acinetobacter
nosocomialis and Acinetobacter pittii (ANAP). Clinical isolates of Acinetobacter spp …

Carbapenem resistance in Acinetobacter spp. is an emerging problem in China. We
investigated the molecular epidemiology and carbapenemase genes of 221 nonrepetitive …

Abstract Objectives Carbapenem-resistant Acinetobacter baumannii (CRAB) has become a
worldwide issue. This study aimed to characterise the epidemiology and genetic …

Nosocomial infections caused by Acinetobacter spp. resistant to carbapenems are
increasingly reported worldwide. Carbapenem-resistant Acinetobacter (CRA) is becoming a …

Carbapenem-resistant Acinetobacter baumannii is a major health problem worldwide,
especially in intensive care units (ICUs). This study aimed to detect the prevalence of A …

Carbapenemases are β-lactamase enzymes that hydrolyze a variety of β-lactams including
carbapenem and belong to different Ambler classes (A, B, D). These enzymes can be …

Carbapenem-resistant Acinetobacter baumannii has spread rapidly across China and is
currently reported to be a worldwide nosocomial menace. In light of its increasing clinical …

The frequency of the carbapenem-resistant Acinetobacter calcoaceticus-Acinetobacter
baumannii (CRACB) complex increases annually in our hospitals. However, the types and …